vs
Side-by-side financial comparison of BioNTech SE (BNTX) and NVR, Inc. (NVR). Click either name above to swap in a different company.
NVR, Inc. is the larger business by last-quarter revenue ($1.8B vs $1.5B, roughly 1.2× BioNTech SE). NVR, Inc. runs the higher net margin — 10.8% vs -1.9%, a 12.7% gap on every dollar of revenue.
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
NVR, Inc. is an American company engaged in home construction headquartered in Reston, Virginia. It also operates a mortgage banking and title services business. The company primarily operates on the East Coast of the United States, but its operations encompass 14 states as well as Washington, D.C. In 2021, 22% of the company's revenue was from the Washington metropolitan area.
BNTX vs NVR — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $1.8B |
| Net Profit | $-28.7M | $198.4M |
| Gross Margin | — | 180.4% |
| Operating Margin | -3.1% | — |
| Net Margin | -1.9% | 10.8% |
| Revenue YoY | — | -21.9% |
| Net Profit YoY | — | — |
| EPS (diluted) | — | $67.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.8B | ||
| Q4 25 | — | $2.7B | ||
| Q3 25 | $1.5B | $2.6B | ||
| Q2 25 | $260.8M | $2.6B | ||
| Q1 25 | — | $2.4B | ||
| Q4 24 | — | $2.8B | ||
| Q3 24 | $1.2B | $2.7B | ||
| Q2 24 | — | $2.6B |
| Q1 26 | — | $198.4M | ||
| Q4 25 | — | $363.8M | ||
| Q3 25 | $-28.7M | $342.7M | ||
| Q2 25 | $-386.6M | $333.7M | ||
| Q1 25 | — | $299.6M | ||
| Q4 24 | — | $457.4M | ||
| Q3 24 | $198.1M | $429.3M | ||
| Q2 24 | — | $400.9M |
| Q1 26 | — | 180.4% | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | -3.1% | — | ||
| Q2 25 | -192.1% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | — | — |
| Q1 26 | — | 10.8% | ||
| Q4 25 | — | 13.4% | ||
| Q3 25 | -1.9% | 13.1% | ||
| Q2 25 | -148.2% | 12.8% | ||
| Q1 25 | — | 12.5% | ||
| Q4 24 | — | 16.1% | ||
| Q3 24 | 15.9% | 15.7% | ||
| Q2 24 | — | 15.3% |
| Q1 26 | — | $67.76 | ||
| Q4 25 | — | $120.85 | ||
| Q3 25 | — | $112.33 | ||
| Q2 25 | — | $108.54 | ||
| Q1 25 | — | $94.83 | ||
| Q4 24 | — | $139.09 | ||
| Q3 24 | — | $130.50 | ||
| Q2 24 | — | $120.69 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $1.6B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $3.5B |
| Total Assets | — | $5.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $1.6B | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $3.5B | ||
| Q4 25 | — | $3.9B | ||
| Q3 25 | — | $4.0B | ||
| Q2 25 | — | $3.8B | ||
| Q1 25 | — | $4.0B | ||
| Q4 24 | — | $4.2B | ||
| Q3 24 | — | $4.3B | ||
| Q2 24 | — | $4.1B |
| Q1 26 | — | $5.6B | ||
| Q4 25 | — | $5.9B | ||
| Q3 25 | — | $6.0B | ||
| Q2 25 | — | $5.9B | ||
| Q1 25 | — | $6.2B | ||
| Q4 24 | — | $6.4B | ||
| Q3 24 | — | $6.5B | ||
| Q2 24 | — | $6.4B |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
